We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Gel Used to Stop Bleeding May Confuse Mammograms

By HospiMedica International staff writers
Posted on 06 May 2009
An American radiologist noticed something odd when she examined the mammogram of a patient who had recently undergone breast cancer surgery. More...
She saw a suspicious pattern of white specks, much like grains of salt. The specks were calcium deposits similar to microcalcifications that sometimes are a sign of early breast cancer. But it was too early for the patient's breast cancer to have returned because it had been only one month since her lumpectomy. It turns out the microcalcifications were not from cancer; instead, they were due to a gel that is sometimes used during surgery to stop bleeding.

Dr. Kathleen Ward and colleagues from Loyola University Health System (Chicago, UL, USA) reported seven cases in which the sealant mimicked malignant microcalcifications in mammograms. The sealant, FloSeal, "is not recommended for use on breast tissue," Dr. Ward and colleagues reported. Dr. Ward is medical director of Women's Health Imaging and an assistant professor in the department of radiology at Loyola University Chicago Stritch School of Medicine.

FloSeal is among the products surgeons use to stop bleeding when sutures or staples are not sufficient or are impractical. FloSeal typically stops bleeding in two minutes or less. "We hope our study will raise awareness for others who may be using this product or any similar product," said first author Dr. Amy Henkel, a third-year radiology resident at Loyola.

Previous studies have described the use of FloSeal in urologic surgery, such as kidney resection, and cardiovascular surgery. FloSeal does not cause imaging problems for those procedures, but should not be used in breast surgery; according to study coauthor Dr. Richard Cooper, a professor in the department of radiology at Stritch. The sealant was developed by Baxter (Deerfield, IL, USA).

The study was published in the November 2008 issue of the American Journal of Roentgenology (AJR). In six patients, the microcalcifications caused by FloSeal were seen on six-month follow-up mammograms. In the seventh patient, these microcalcifications were seen on a mammogram taken one month after lumpectomy to look for residual malignant calcifications.

Related Links:

Loyola University Health System



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.